Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease
Public ClinicalTrials.gov record NCT00846586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Controlled, Parallel-group, 12-week Study to Compare the Efficacy and Safety of the Combination of Indacaterol 150 µg Once Daily With Open Label Tiotropium 18 µg Once Daily Versus Open Label Tiotropium 18 µg Once Daily in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in patients with chronic obstructive pulmonary disease (COPD)
Study identification
- NCT ID
- NCT00846586
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,134 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Mar 2010 (Actual)
- Completion
- Mar 2010 (Actual)
- Last update posted
- Aug 18, 2011
2009 – 2010
United States locations
- U.S. sites
- 61
- U.S. states
- 30
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigator Site | Birmingham | Alabama | 32509 | — |
| Novartis Investigator Site | Mobile | Alabama | 36608 | — |
| Novartis Investigative Site | Scottsdale | Arizona | 85258 | — |
| Novartis Investigative Site | Tucson | Arizona | 85712 | — |
| Novartis Investigative Site | Tucson | Arizona | 85723 | — |
| Novartis Investigator Site | Pine Bluff | Arkansas | 71603 | — |
| Novartis Investigator Site | Fountain Valley | California | 92708 | — |
| Novartis Investigator Site | Long Beach | California | 90822 | — |
| Novartis Investigative Site | Los Angeles | California | 90095 | — |
| Novartis Investigator Site | National City | California | 91950 | — |
| Novartis Investigator Site | Palmdale | California | 93551 | — |
| Novartis Investigative Site | Stockton | California | 95207 | — |
| Novartis Investigator Site | Temecula | California | 92591 | — |
| Novartis Investigative Site | Hartford | Connecticut | 06105-1208 | — |
| Novartis Investigative Site | Clearwater | Florida | 33756 | — |
| Novartis Investigator Site | Fort Walton Beach | Florida | 32547 | — |
| Novartis Investigative Site | Miami | Florida | 33136 | — |
| Novartis Investigative Site | Miami | Florida | 331577 | — |
| Novartis Investigative Site | Naranja | Florida | 33032 | — |
| Novartis Investigator Site | Pensacola | Florida | 32514 | — |
| Novartis Investigator Site | Sarasota | Florida | 34233 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30342 | — |
| Novartis Investigator Site | Conyers | Georgia | 30094 | — |
| Novartis Investigative Site | Normal | Illinois | 61761 | — |
| Novartis Investigative Site | Iowa City | Iowa | 52240 | — |
| Novartis Investigative Site | Kansas City | Kansas | 66160 | — |
| Novartis Investigative Site | Lenexa | Kansas | 66215 | — |
| Novartis Investigative Site | Topeka | Kansas | 66606 | — |
| Novartis Investigator Site | Lafayette | Louisiana | 70503 | — |
| Novartis Investigator Site | Metaire | Louisiana | 70002 | — |
| Novartis Investigator Site | New Orleans | Louisiana | 70119 | — |
| Novartis Investigator Site | Slidell | Louisiana | 70458 | — |
| Novartis Investigator Site | Columbia | Maryland | 21044 | — |
| Novartis Investigator Site | Brockton | Massachusetts | 02301 | — |
| Novartis Investigator Site | Clarkston | Michigan | 48346 | — |
| Novartis Investigator Site | Detroit | Michigan | 48202 | — |
| Novartis Investigative Site | Saint Charles | Missouri | 63301 | — |
| Novartis Investigator Site | Missoula | Montana | 59808 | — |
| Novartis Investigator Site | Boys Town | Nebraska | 68010 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68114 | — |
| Novartis Investigative site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89119 | — |
| Novartis Investigator Site | Lebanon | New Hampshire | 03756 | — |
| Novartis Investigator Site | Asbury Park | New Jersey | 07712 | — |
| Novartis Investigative Site | Rochester | New York | 14618 | — |
| Novartis Investigator Site | Mooresville | North Carolina | 28117 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigator Site | Tulsa | Oklahoma | 74135-2920 | — |
| Novartis Investigative Site | Medford | Oregon | 97504 | — |
| Novartis Investigator Site | Bethlehem | Pennsylvania | 18020 | — |
| Novartis Investigative Site | Cumberland | Rhode Island | 02864 | — |
| Novartis Investigator Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Novartis Investigator Site | Knoxville | Tennessee | 37919 | — |
| Novartis Investigator Site | El Paso | Texas | 79903 | — |
| Novartis Investigative Site | Houston | Texas | 77024 | — |
| Novartis Investigative Site | Houston | Texas | 77079 | — |
| Novartis Investigative Center | New Braunfels | Texas | 78130-6113 | — |
| Novartis Investigator Site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Richmond | Virginia | 23225 | — |
| Novartis Investigator Site | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00846586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00846586 live on ClinicalTrials.gov.